Calibrating Models in Economic Evaluation

[1]  Milton C. Weinstein,et al.  Recent Developments in Decision-Analytic Modelling for Economic Evaluation , 2012, PharmacoEconomics.

[2]  J. Karnon.  Aromatase Inhibitors in Breast Cancer , 2012, PharmacoEconomics.

[3]  Natasha K. Stout,et al.  Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines , 2012, PharmacoEconomics.

[4]  Jonathan Karnon,et al.  Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.

[5]  John K Kruschke,et al.  Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.

[6]  Singiresu S. Rao.  Engineering Optimization : Theory and Practice , 2010 .

[7]  Peter Vickerman,et al.  Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme , 2010, Sexually Transmitted Infections.

[8]  M. Jit,et al.  Estimating Progression Rates for Human Papillomavirus Infection From Epidemiological Data , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[9]  Simon G Thompson,et al.  Uncertainty and validation of health economic decision models. , 2009, Health economics.

[10]  D. De Angelis,et al.  An evidence synthesis approach to estimating Hepatitis C Prevalence in England and Wales , 2009, Statistical methods in medical research.

[11]  J. Alvidrez,et al.  Risk perception and preference for prevention of Alzheimer's disease. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  G Scott Gazelle,et al.  Calibration of disease simulation model using an engineering approach. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[13]  J. Karnon,et al.  Model-based cost-effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation). , 2009, Journal of evaluation in clinical practice.

[14]  Jonathan Karnon,et al.  A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[15]  G Scott Gazelle,et al.  Adopting helical CT screening for lung cancer , 2008, Cancer.

[16]  Nicky J Welton,et al.  Multiparameter evidence synthesis in epidemiology and medical decision-making , 2008, Journal of health services research & policy.

[17]  F. Bruinsma,et al.  Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia , 2008, BMJ : British Medical Journal.

[18]  Chien-Jen Chen,et al.  Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios. , 2008, Vaccine.

[19]  J. Karnon,et al.  Cost-utility analysis of screening high-risk groups for anal cancer. , 2008, Journal of public health.

[20]  Joakim Dillner,et al.  Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. , 2008, Vaccine.

[21]  Mark Jit,et al.  Economic evaluation of human papillomavirus vaccination in the United Kingdom , 2008, BMJ : British Medical Journal.

[22]  J. Karnon,et al.  The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation. , 2008, Health technology assessment.

[23]  Catherine H Mercer,et al.  Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data , 2008 .

[24]  M. Shanahan,et al.  The cost‐effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range? , 2008, Australian and New Zealand journal of public health.

[25]  Jonathan Karnon,et al.  Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective , 2008, The European Journal of Health Economics.

[26]  E Goyder,et al.  A review and critique of modelling in prioritising and designing screening programmes. , 2007, Health technology assessment.

[27]  Jeremy D Goldhaber-Fiebert,et al.  Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination , 2007, Population health metrics.

[28]  M. Keeling,et al.  Modeling Infectious Diseases in Humans and Animals , 2007 .

[29]  Jeremy D Goldhaber-Fiebert,et al.  Cost-effectiveness of HPV 16, 18 vaccination in Brazil. , 2007, Vaccine.

[30]  M. Aalabaf-Sabaghi.  Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.

[31]  Karen M Kuntz,et al.  Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.

[32]  M. Weinstein,et al.  MC1 METHODS OF MODEL CALIBRATION:A COMPARATIVE APPROACH , 2007 .

[33]  Marie-Claude Boily,et al.  Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty. , 2007, American journal of epidemiology.

[34]  Tejal K. Gandhi,et al.  A prospective hazard and improvement analytic approach to predicting the effectiveness of medication error interventions , 2007 .

[35]  Deborah Caldwell.  Decision Modelling for Health Economic Evaluation. A Briggs, M Sculpher, K Claxton , 2007 .

[36]  A. Pettitt,et al.  Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data. , 2007, Biostatistics.

[37]  P Tappenden,et al.  Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. , 2007, Health technology assessment.

[38]  C. Watts,et al.  Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? , 2007, Addiction.

[39]  C. Marriott.  ISPOR 12th Annual International Meeting , 2007 .

[40]  P. Tappenden,et al.  Option appraisal of population-based colorectal cancer screening programmes in England , 2006, Gut.

[41]  Natasha K. Stout,et al.  Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .

[42]  Jennifer Cullen,et al.  The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. , 2006, Journal of the National Cancer Institute. Monographs.

[43]  S. Moses,et al.  What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India , 2006, Sexually Transmitted Infections.

[44]  Jeremy E. Oakley,et al.  Uncertain Judgements: Eliciting Experts' Probabilities , 2006 .

[45]  Grazyna Adamiak,et al.  Methods for the economic evaluation of health care programmes, 3rd ed , 2006 .

[46]  M. Sculpher,et al.  Decision Modelling for Health Economic Evaluation , 2006 .

[47]  J. Berkhof,et al.  Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis , 2006, International journal of cancer.

[48]  A E Ades,et al.  Evidence synthesis, parameter correlation and probabilistic sensitivity analysis. , 2006, Health economics.

[49]  Vipat Kuruchittham,et al.  The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.

[50]  J. Forbes,et al.  A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. , 2005, The New England journal of medicine.

[51]  Thomas J. Smith,et al.  Review: chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer , 2005, ACP journal club.

[52]  N. Welton,et al.  Estimation of Markov Chain Transition Probabilities and Rates from Fully and Partially Observed Data: Uncertainty Propagation, Evidence Synthesis, and Model Calibration , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[53]  T. Wright,et al.  Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. , 2005, Journal of the National Cancer Institute.

[54]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[55]  Nicky J Welton,et al.  A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence , 2005 .

[56]  M Baum,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[57]  A. Brix.  Bayesian Data Analysis, 2nd edn , 2005 .

[58]  Alex Alves Freitas,et al.  A critical review of multi-objective optimization in data mining: a position paper , 2004, SKDD.

[59]  M Sculpher,et al.  Health Technology Assessment: Development and Future , 2009 .

[60]  B. Yegnanarayana,et al.  Artificial Neural Networks , 2004 .

[61]  W. Press,et al.  Numerical Recipes in C++: The Art of Scientific Computing (2nd edn)1 Numerical Recipes Example Book (C++) (2nd edn)2 Numerical Recipes Multi-Language Code CD ROM with LINUX or UNIX Single-Screen License Revised Version3 , 2003 .

[62]  Nanda Piersma,et al.  Estimating Parameters of a Microsimulation Model for Breast Cancer Screening Using the Score Function Method , 2000, Ann. Oper. Res..

[63]  J. Curry,et al.  CONFRONTING MODELS WITH DATA , 2003 .

[64]  Milton C Weinstein,et al.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[65]  W. Edmunds,et al.  Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales , 2002, BMJ : British Medical Journal.

[66]  M. Drummond,et al.  Economic Evaluation in Health Care: Merging Theory with Practice , 2002 .

[67]  J. Dayhoff,et al.  Artificial neural networks , 2001, Cancer.

[68]  M. Weinstein,et al.  The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women , 1999, Annals of Internal Medicine.

[69]  Leon S. Lasdon,et al.  Design and Use of the Microsoft Excel Solver , 1998, Interfaces.

[70]  Samuel S. M. Wong.  Computational methods in physics and engineering (2nd ed.) , 1997 .

[71]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[72]  A. Roli.  Artificial Neural Networks , 2012, Lecture Notes in Computer Science.

[73]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[74]  Joel A. Shapiro,et al.  Computational Methods In Physics And Engineering , 1993 .

[75]  William H. Press,et al.  The Art of Scientific Computing Second Edition , 1998 .

[76]  G. Box,et al.  Empirical Model-Building and Response Surfaces. , 1990 .

[77]  George E. P. Box,et al.  Empirical Model‐Building and Response Surfaces , 1988 .

[78]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[79]  M. Drummond,et al.  Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .

[80]  William H. Press,et al.  Numerical recipes in C. The art of scientific computing , 1987 .

[81]  Philip E. Gill,et al.  Practical optimization , 1981 .

[82]  G. Mooney,et al.  Economic analysis in health care. , 1981, Health bulletin.

[83]  Leon S. Lasdon,et al.  Design and Testing of a Generalized Reduced Gradient Code for Nonlinear Programming , 1978, TOMS.

[84]  K. Popper,et al.  Conjectures and refutations;: The growth of scientific knowledge , 1972 .